Spironolactone ameliorates the cardiovascular toxicity induced by concomitant trastuzumab and thoracic radiotherapy


Yavas G., Celik E., Yavas C., Elsurer C., Afsar R.

REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, cilt.22, sa.4, ss.295-302, 2017 (ESCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22 Konu: 4
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1016/j.rpor.2017.01.004
  • Dergi Adı: REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY
  • Sayfa Sayıları: ss.295-302

Özet

Aim: We aimed to evaluate impact of spironolactone (S) on cardiovascular toxicity of concomitant use of radiotherapy (RT) and trastuzumab (T).